Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay

Neuropharmacology

Volumn 35, Issue 4, 1996, Pages 393-405

  Rao, Tadimeti S ^a   Correa, Lucia D ^a   Reid, Richard T ^a   Lloyd, G Kenneth ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Acetylcholine nicotinic receptor; anti nociception; DSP 4 N (2 chloroethyl) N ethyl 2 bromobenzylamine ; epibatidine; methyllycaconitine; nicotine; tail flick response

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYTISINE; EPIBATIDINE; METHYLCARBACHOL; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

EID: 0029927101     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)00013-5     Document Type: Article

References (66)

1. Aceto M. D., Bagley R. S., Dewey W. L., Fu T.-C. and Martin B. R. (1986) The spinal cord as a major site for the anti-nociceptive action of nicotine in the rat. Neuropharmacology 25: 1031-1036.
2. Aceto M. D., Martin B. R., Tripathi H. L., May E. L. and Jacobsen A. E. (1980) Antinociceptive effect of opticallypure stereoisomers of nicotine. Pharmacologist 22: 302.
3. 3H]-methylcarbamylcholine in rat brain. Eur. J. Pharmacol. 253: 261-267.
4. Archer T., Jonsson G., Minor B. G. and Post C. (1986) Noradrenergic-serotoninergic interactions and nociception in the rat. Eur. J. Pharmacol. 120: 295-307.
5. Arqueros L., Naquira D. and Zuinino E. (1978) Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol. 27: 2667-2674.
6. Asghar K. and Roth L. J. (1971) Entry and distribution of hexamethonium in the central nervous system. Biochem. Pharmacol. 20: 2787-3795.
7. Badio B., and Daly J. W. (1994) Epibatidine, a potent analgesic and nicotinic agonist. Molec. Pharmacol. 45: 563-569.
8. Balbian-Verster F., Robinson C. A., Hengeveld C. A. and Bush E. S. (1971) Freehand cerebroventricular injection for unanesthetized rats. Life Sci. 10: 1395-1402.
9. Besson J.-M. and Chaouch A. (1987) Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67: 67-196.
10. Block R. C., Chin C. W. Y., Wu W. and Zbuzek V. K. (1993) Nicotine-induced analgesia in rats: The role of calcium and the diversity of responders and non-responders. Life Sci. 53: 195-200.
11. 3H]-N-methyl-carbamylcholine, a new radioligand specific for receptors in brain. Eur. J. Pharmacol. 139: 323-333.
12. Christensen M. K. and Smith D. F. (1990) Antinociceptive effects of the stereoisomers of nicotine given intrathecally in spinal rats. J. Neural Transm. Gen. Sect. 80: 189-194.
13. Clarke P. B. S. and Pert A. (1985) Autoradiographic evidence for nicotinic receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348: 355-358.
14. 125I]-α-bungarotoxin. J. Neurosci. 5: 1307-1315.
15. D'Amour F. E. and Smith D. L. A method for determining loss of pain sensation. (1941) J. Pharmacol. Exp. Ther. 72: 74-79.
16. Dahlstrom A. and Fuxe K. (1964) Evidence for the existence of monoamine containing neurons in the central nervous system I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta. Physiol. Scand (Suppl.) 232: 1-55.
17. Davis L., Pollock L. J. and Stone T. T. (1932) Visceral pain. Surg. Gynaecol. Obstet. 55: 418-426.
18. Dayton H. E. and Garrett R. L. (1973) Production of analgesia by cholinergic drugs. Proc. Soc. exp. biol. Med. 142: 1011-1013.
19. Domino E. F. (1979) Behavioral, electrophysiological, endocrine and skeletal muscle actions of nicotine and tobacco smoking. In Electrophysiological Effects of Nicotine (Redmond A. and Izard C., Eds), pp. 133-146. Elsevier/North Holland Biomedical Press, Amsterdam.
20. Donzanti B. B. and Yamamoto B. Y. (1988) An improved and rapid HPLC-EC method for isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci. 43: 913-922.
21. Drasdo A., Caulfield M., Betrand D., Betrand S. and Wonnacott S. (1992) Methyllcaconitine: a novel nicotinic agonist. Molec. Cell. Neurosci. 3: 237-243.
22. Fritschy J.-M., and Grzanna R. (1989) Immunohistochemical analysis of neurotoxic effects of DSP-4 identifies two population of noradrenergic axon terminals. Neuroscience 30: 181-197.
23. Grzanna T., Berger U., Fritschy J.-M., Geffard M. (1989) Acute actions of DSP-4 on central norepinephrine axons : biochemical and immunohistochemical evidence for differential effects. J. Histochem. Cytochem. 37: 1435-1442.
24. Hallman H., Sundstrom E. and Johnsson G. (1984) Effects of the noradrenaline neurotoxin DSP-4 on monoamine neurons and their transmitter turnover in the rat CNS. J. Neural Transm. 60: 89-102.
25. Hamann S. R. and Martin W. R. (1991) Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem. J. Pharmacol. exp. Ther. 261: 707-715.
26. Ireson J. D. (1970) A comparison of the antinociceptive actions of cholinomimetic and morphine-like drugs. Br. J. Pharmacol. 40: 92-101.
27. Iwamoto E. T. (1989) Antinociception after nicotine administration into the mesopontine tegmentum of rats: Evidence for muscarinic actions. J. Pharmacol. exp. Ther. 251: 412-442.
28. Iwamoto E. T. (1991) Characterization of the anti-nociception induced by nicotine in the pedunculopontine tegmental nucleus and nucleus raphe magnus. J. Pharmacol. exp. Ther. 257: 120-133.
29. Iwamoto E. T. and Marion L. (1993) Adrenergic, serotonergic and cholinergic components of nicotinic anti-nociception in rats. J. Pharmacol. exp. Ther. 265: 286-293.
30. Jinno S., Hua X.-Y. and Yaksh T. L. (1994) Nicotine and acetylcholine induce release of calcitonin gene-related peptide form rat trachea. J. appl. Physiol. 76: 1651-1656.
31. Jonsson G., Hallman, H., Ponzio F. and Ross S. (1981) DSP-4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine - A useful denervation tool for central and peripheral noradrenaline neurons. Eur. J. Pharmacol. 72: 173-188.
32. Jurna I., Krauss P. and Baldauf J. (1993) Depression by nicotine of pain-related nociceptive activity in the rat thalamus and spinal cord. Clin. Invest. 72: 65-73.
33. Kammerling S. G., Wettstein J. G., Sloan J. W., Su T.-P. and Martin W. R. (1982) Interaction between nicotine and endogenous opioid mechanism in the unanesthetized dog. Pharmacol. biochem. Behav. 17: 733-740.
34. Khan I. M., Taylor P. and Yaksh T. Y. (1994) Cardiovascular and behavioral responses to nicotinic agents. J. Pharmacol. exp. Ther. 270: 150-158.
35. Khan I., Yaksh T. L. and Taylor P. (1994) Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: Studies with nicotine and cytisine. J. Pharmacol. exp. Ther. 270: 159-166.
36. Lookingland K. J., Chapin D. S., Mckay D. W. and Moore K. E. (1986) Comparative effects of neurotoxins, N-chloroethyl-2-bromobenzylamine hydrochloride (DSP-4) and 6-hydroxy-dopamine on hypothalamic noradrenergic, dopaminergic and 5-hydroxytryptaminergic neurons in the male rat. Brain Res. 365: 228-234.
37. Marks M. J. and Collins A. C. (1982) Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Molec. Pharmacol. 22: 554-564.
38. Martin B. R., Tripathi H. L., Aceto M. D. and May E. L. (1983) Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions. J. Pharmacol. exp. Ther. 226: 157-163.
39. Martin W. R., Kumar S. and Sloan J. W. (1988) Opioid and nicotinic medullary hyperalgesic influences in decerebrated rat. Pharmacol. Biochem. Behav. 29: 725-731.
40. Mattila M. J., Ahtie L. and Saarnivara L. (1968) The analgesic and sedative effects of nicotine in white mice, rabbits and golden hamsters. Ann. med. exp. Biol. Fenn. 46: 78-74.
41. O'Callaghan J. P. and Holtzman S. G. (1975) Quantitation of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J. Pharmacol. exp. Ther. 192: 497-505.
42. Papke R. L. (1993) The kinetic properties of neuronal nicotinic receptors : genetic basis of functional diversity. Prog. Brain. Res. 41: 561-569.
43. Parvini S., Hamnann S. R. and Martin W. R. (1993) Pharmacologic characteristics of a medullary hyperalgesic center. J. Pharmacol. exp. Ther. 265: 286-293.
44. Pert A. (1987) Cholinergic and catecholaminergic modulation of nociceptive reactions. In Pain and Headache, Vol. 9, Neurotransmitters and Pain Control (Akil H. and Lewis J. W., Eds), pp. 1-63, Karger, Basel.
45. Petersson J., Gordh T. E., Hartvig P. and Wiklund L. (1986) A double-blind trial of the analgesic properties of physostigmine in post-operative patients. Acta Anesthesiol. Scand. 30: 283-288.
46. Phan D. V., Doda M., Bite A. and Gyorgy L. (1973) Antinociceptive activity of nicotine. Acta Physiol. Acad. Sci. Hung. 44: 85-93.
47. Pomerleau O. F., Turk D. C. and Fertig J. B. (1984) The effects of cigarette smoking on pain and anxiety. Addictive Behav. 9: 265-271.
48. Qian C., Li T., Shen T. Y., Libetine-Garahan L., Eckman J., Biftu T. and Ip, S. (1993) Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250: R13-R14.
49. Reddy S. V. R. and Yaksh T. (1980) Spinal noradrenergic terminal system mediated Antinociception. Brain Res. 189: 391-398.
50. Rupniak N. M. J., Patel S., Marwood R., Webb J., Traynor J. R., Elliot J., Freedman S. B., Fletcher S. R. and Hill R. G. (1994) Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity. Br. J. Pharmacol. 113: 1487-1493.
51. Sacaan A. I., Dunlop J. L. and Lloyd G. K. (1995) Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. exp. Ther. 274: 224-230.
52. Sahley T. L. and Bernston G. G. (1979) Antinociceptive effects of central and systemic administrations of nicotine in the rat. Psychopharmacology 65: 279-283.
53. Samanin R., Bernasconi S. and Quarttrone A. (1976) Antinociceptive actions of quipazine : relation to central serotoninergic receptor stimulation. Psychopharmacology 46: 219-225.
54. 3H]-acetylcholine on catecholamine and serotonin axons. J. Neurochem. 42: 1495-1498.
55. Smith P. K., Krohn R. I., Hermanson G. T., Malia A. K., Gartner F. H., Provenazo M. D., Fujimoto E. K., Goeke N. M., Olson B. J. and Klenk D. C. (1985) Measurement of protein using bicinchonic acid. Analyt. Biochem. 150: 76-85.
56. Smith M. D., Yang X., Nha J.-Y., Buccafusco J. J. (1989) Anti-nociceptive effect of spinal cholinergic stimulation : interaction with substance P. Life Sci. 45: 1255-1261.
57. Spande T. F., Garraffo H. M., Edwards M. W., Yeh H. J. C., Pannell L. and Daly J. W. (1992) Epibatidine: A novel (chloropyridyi)azabicycloheptane with potent analgesic activity from an Ecuadorian poison frog. J. Am. Chem. Soc. 114: 3475-3478.
58. Tripathi H. L., Martin B. R. and Aceto M. D. (1982) Nicotine-induced anti-nociception in rats and mice : correlation with nicotine brain levels. J. Pharmacol. exp. Ther. 221: 91-96.
59. Waller D., Schalling D., Lavender S. and Edman G. (1983) Smoking, pain tolerance, and physiological activation. Psychopharmacology 59: 193-198.
60. Westfall T. C., Grant H. and Perry H. (1983) Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen. Pharmacol. 14: 321-325.
61. Williams M., Sullivan J. P. and Arneric S. P. (1994) Neuronal nicotinic acetylcholine receptors. Drug News and Perspect. 7: 205-223.
62. Yaksh T. L., Dirksen R. and Harty G. J. (1985) Anti-nociceptive effects of intrathecal cholinomimetic drugs in the rat and cat. Eur. J. Pharmacol. 117: 81-88.
63. Yamada S., Kagawaa Y., Takayanagi N., Hayashi E., Tsuji K. and Kosuge T. (1986) Inhibition by neosuragatoxin of nicotine-induced anti-nociception. Brain Res. 375: 360-362.
64. Yamamura H. I. and Snyder S. H. Muscarinic cholinergic binding in rat brain. (1974) Proc. natn. Acad. Sci. U.S.A. 71: 1725-1729.
65. Zaczek R., Fritschy J.-M., Culp S., De Souza E. B. and Grzanna R. (1990) Differential effects of DSP-4 on noradrenaline axons in cerebral cortex and hypothalamus may reflect heterogeneity of noradrenergic uptake sites. Brain Res. 522: 308-314.
66. Zelman F. P., Corrigan S. A. and Pfaff D. W. (1980) Noradrenergic and serotoninergic mediation of spinal analgesia. Eur. J. Pharmacol. 61: 111-124.